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Introduction 
Though Histoplasmosis was first 
recognized as a disease entity in 1905 by 
Darling in the Panama Canal Zone, it was 
still considered a rarity up till 1945. It was 
only when the frequency of the positive 
skin reaction to the histoplasmin test was 
reported first by Palmer (1945), and then 
by Christie and Petersen (1945), that the 
disease acquired epidemiological and cli-
nical importance, with the result that it is 
currently estimated that 40 million people 
have been infected by the fungus, Histo-
plasma capsulatum, and that a signi~icant 
proportion of the 500,000 annual mfec-
tions are severe enough to require medi-
cal treatment (Chick, 1971). 
Histoplasmosis is endemic only in the 
Eastern Central United States of America 
but cases have been reported in various 
parts of the World including some Euro-
pean countries, such as the Nederlands, 
England, France and Italy (Tassinari, 
1948) as well as places in the Mediterra-
nean. 
In view of the presence of the disease 
along the Southern shores of nearby Italy 
where the fungus was cultivated from the 
soil (Murray, 1969), it was considered 
worth wile to carry out a pilot survey to 
ascertain the local histoplasmin reactivity, 
even though so far no case of histoplasmo-
sis has been diagnosed in Malta. 
Methods 
The population chosen to be tested 
consisted of a selected group having the 
following characteristics: 
a) All had pulmonary tuberculosis, 
with the disease healed or in the inactive 
stage - thus having a pulmonary patho-
logy similar to that of histoplasmosis; 
b) All came from a rural or former 
rural area, and therefore were more likely 
to have come in contact with a possible 
source; 
c) All belonged to the age-group 40-
60 years, i.e. had already been born when 
a larger part of Malta could be descrbed as 
rural. 
A Histoplasmin Skin Test was carried 
out by the Mantoux Method in 461 persons 
(315 men, 146 women) coming from 30 
rural areas and from 14 towns, the area 
representation being quite comprehensive; 
all the tests were carried out and read by 
the same individual. 
The antigen used was a standardized 
sterile filtrate from cultures of Histoplas-
ma capsulatum grown on liquid synthetic 
medium, equal in potency to Reference 
Histoplasmin; O.lce of this antigen was in-
jected intradermally in the volar surface 
of the left fore-arm, the test being read 48 
hours later. A positive reaction was taken 
as an induration of 5 mm or more; as with 
the Tuberculin Test, erythema without in-
duration was not taken as a positive res-
ponse. 
All tests gave negative results. 
Discussion 
Systemic primary fungal infestation 
is rare in Malta. As far as could be ascer-
tained only four cases of this type of fun-
gal disease have been seen or reported lo-
cally: a Cryptococcal meningitis in a mid-
dIe-aged man, a diffuse Nocardiosis in a 
young boy, localised pulmonary Nocardio-
sis in another case and a pleural effusion 
caused by Penicillium lilacinum (Fenech 
and Mallia, 1972) in a fourth. 
No case of pulmonary aspergillosis, 
diffuse or localised, has been seen locally 
in spite of a careful look-out extending 
over 20 years, and no other funghi have 
been isolated at the Bacteriological Labo-
ratories of the Health Department ex-
cept those already mentioned (Agius, 
1973; Spiteri, 1973). 
It had been suggested that the best 
condition for the growth of H.capsulatum 
in nature include (a.) red-yellow podzolic 
soil under certain conditions of tempera-
ture (16° - 32°C) and humidity (relative 
humidity 50% or more), enriched by bird 
manure, and (b.) elevation above sea-le-
vel of from 500 to 1,000ft. (Addington, 
1967; Manos et aL 1956); ]jut it r,ow ap-
pears that such soil is not indispensable 
for the growth of the fungus. In fact Chick 
et al (1972) have isolated the H.capsula-
tum from bat manure obtained from the 
concrete block wall of an abandoned build-
ing, and this was the source of infection in 
at least one case reported by them. There 
is no red podzolic soil in Malta, but bats 
are prevalent. 
There is no evidence of direct spread 
from animals to humans or from humans 
to animals or that histoplasmosis is a con-
tagious disease (Addington, 1967). Prior 
(1951) has however suggested that there 
may be transmission from animal to ani-
mal (dog), in fact in certain areas of the 
U.S.A. up to 50% of dogs are serologically 
positive, and the majority culturally posi-
tive on autopsy (Chick, 1971). The mode 
of infection is by inhalation of airborne 
spores, and the natural reservoir of the 
fungus is its saprophytic growth in nature 
from where it is spread to humans (Gray-
ston and Furcolow, 1953; Furcolow, 1960; 
Lash, 1960). 
Histoplasmosis has a clinical and pa-
thological similarity to many diseases. It 
may be confused with Kala-azar (irregular 
fever, splenomegaly, leucopenia, inclusion 
bodies in endothelial cells), the Reticu-
loses (enlargement of liver, spleen, glands, 
leucopenia and anaemia), and, because of 
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the pulmonary changes, with tuberculo-
sis. In fact it can simulate any illness, but 
it is primarily granulomatous in nature 
and the fungus is highly invasive to the 
reticulo-endothelial system. 
As the disease is acquired by way of 
the respiratory tract, almost without ex-
ception the respiratory organs are the 
most common site of the primary infec-
tion, mimicking tuberculosis very strong-
ly. Four types of pulmonary lesions are 
recognized: 
1. A primary complex - having the 
same size, shape and localization as in tu-
berculosis. 
2. Miliary lung - the most common. 
3. Coin lesions, multiple or single, 
simulating malignancy. 
4. Cavity formation, especially in 
adults. 
Because of the multiplicity of the cli-
nical man.iicstnti:::ns, [t dlagnosis of histo-
plasmosis can only be confirmed by spe-
cial laboratory investigations i.e. serology, 
mycology, and skin sensitivity tests. 
Conclusion 
The findings of the present pilot sur-
vey indicate that one is unlikely to come 
across endogenous histoplasmois, yet, in 
view of the rapid increase in travel 
throughout the World, the possibility of 
meeting with imported disease has to be 
seriously considered. 
Our thanks are due to Dr. J. Psaila 
Savona who carried out and read the His-
toplasmin Tests, and to Messrs Parke-
Davis Ltd., who very kindly supplied the 
Histoplasmin antigen. 
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Department of Venereo~ogy and Dermatology, 
St. Luke's Hospita~ 
Clocortolone pivalate (Purantix(R) 
Sandoz) is a new dihalogenated cortico-
steroid for topical use, 9a-Chloro-6a-fluoro-
II,e, 21-dihydroxy-16a methyl-pregna-1, 4-
diene-3,20-dione 21 pivalate. Its anti-
inflammatory action and good tolerance 
have been demonstrated in animal experi-
ments. In the granuloma-pouch test, its act-
ivity when administered by the oral or sub-
cutaneous route has been shown to be 
approximately thirty times that of hydro-
cortisone acetate. An open clinical triai was 
undertaken to evaluate its efficacy and 
tolerance, when used at a concentration of 
0.1 % in an oil-in-water base, in dermatoses 
normally responsive to topical corticoste-
roids. . 
Method 
One hundred and one patients with the 
following diagnoses were treated: 
Psoriasis vulgaris (20) 
Contact dermatitis (23) 
Lichen chronicus simplex (9) 
Atopic dermatitis (6) 
Pompholyx (3) 
Seborrhoeic eczema (2) 
Nummular eczema (2) 
Pruritus in association with varicose 
veins (I) 
Infective dermatitis (I) 
Acne vulgaris (9) 
Keloid scars (8) 
Pruritus ani (5) 
Herpes simplex (I) 
Pityriasis rubra pilaris (I) 
Dermatitis papillaris capilliti (2) 
Fifty-three of these patients were male 
and forty-eight female. Only five were in-
patients. Ages ranged from 3 months'to 75 
years but 87 were over 14. The cream was 
applied two to four times daily, in con-
formity with normal practice,and was con-
tinued until its maximum effect was 
deemed to have been achieved. This 
averaged 26.7 days (range 8-51 days). Two 
patients only were treated for part of the 
time with occlusive dressings which were 
changed 3 and 7 times per week respec-
